BNTC
Closed
Benitec Biopharma Ltd Adr
12.11
+0.41 (+3.50%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 11.7
Day's Range: 11.215 - 12.5
Send
sign up or login to leave a comment!
When Written:
0.2099
Benitec Biopharma Ltd ADR is a biotechnology company that focuses on the development of RNA interference (RNAi) therapeutics for the treatment of various diseases. The company's proprietary gene-silencing technology, called ddRNAi, targets and silences specific genes that are involved in the development and progression of diseases such as hepatitis C, HIV, and cancer. Benitec Biopharma's lead product candidate, BB-301, is being developed for the treatment of oculopharyngeal muscular dystrophy (OPMD), a rare genetic disorder that affects the muscles used for swallowing and speaking. The company is headquartered in Sydney, Australia, and its ADRs trade on the NASDAQ under the ticker symbol "BNTC."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








